Bayer receives FDA approval for AMBELVIST MRI contrast agent

AstraZeneca secures US approval for Truqap combination in PTEN‑deficient prostate cancer

Acousia Therapeutics reports positive top-line efficacy results for ACOU085 in cisplatin-induced ototoxicity

Menarini reports Phase 3 data for selinexor plus ruxolitinib in myelofibrosis

Simcere Pharmaceutical and Stanford Medicine agree research collaboration in idiopathic pulmonary fibrosis

Gilead Sciences mobilises remdesivir donation to support Ebola response in Uganda

Airiver Medical treats first chronic rhinosinusitis patient in Drug Coated Balloon clinical study

Precigen and the RRPF recognise International RRP Awareness Day

Roche secures IVDR approval to expand VENTANA MMR RxDx Panel indications

Guardant Health expands FDA-approved companion diagnostic use for HERNEXEOS

PharmaEssentia expands North American footprint with acquisition of Canadian partner FORUS Therapeutics

FDA grants priority review for Genentech's Tecentriq in stage III dMMR/MSI-H colon cancer

Harbour BioMed IND for HBM7004 accepted by China's NMPA

Organon secures FDA approval expanding TOFIDENCE indications for CRS and paediatric COVID-19

Sanofi halts phase 3 MOBILIZE study of riliprubart in CIDP